Powering precision medicine for the brain

Beacon’s EEG neurobiomarker platform is engineered to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric disease.

What We Do

  • Efficacy

    Quantitative assessment of treatment impact on EEG and ERP data ensure clinical endpoints are reached

  • Safety Monitoring

    EEG reports delivered with unprecedented speed and accuracy, eliminating adjudication with enhanced inclusion/exclusion criteria

  • Population Stratification

    Identify optimal patient populations to maximize effective treatments

Enabled by our end-to-end augmented EEG platform

  • State of the Art Machine Learning

  • World-Class Clinical EEG Database

  • Expert Neurologist Network

How We Create Impact

  • Translational Research

    Analyze existing EEG for insights into mechanism, PK/PD and patient stratification to guide further development efforts

  • Clinical Trial Optimization

    Improved cohort selection and proactive in-trial monitoring can mitigate risk of trial failure due to severe side effects or missed endpoints

  • Commercial Differentiation

    Best-in-class safety profiles and at-home monitoring are highly valued by both patients and clinicians



We partner with biopharma companies, academic medical centers, and neurotechnology developers to improve the diagnosis and treatment of neurological and psychiatric diseases.

Learn More